NASDAQ:XERS | Total Liabilities | Xeris Biopharma Holdings, Inc.

Complete source-backed total liabilities history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Total Liabilities

DateTotal liabilitiesCurrent liabilitiesAccounts payableNoncurrent debtOther noncurrent liabilities
2026-06-30$421.64M$189.57M$9.34M$188.81M$12.72M
2026-03-31$379M$118.59M$11.47M$221.22M$8.13M
2025-12-31$369.84M$109.57M$3.08M$220.34M$8.4M
2025-09-30$371.05M$116.2M$6.53M$219.47M$3.39M
2025-06-30$353.99M$95.17M$9.46M$218.63M$7.75M
2025-03-31$350.58M$95.07M$6.35M$217.81M$4.83M
2024-12-31$352.68M$100.44M$2.29M$217.01M$1.97M
2024-09-30$349.43M$91.01M$7.45M$216.23M$8.55M
2024-06-30$351.02M$75.49M$5.8M$230.48M$7.71M
2024-03-31$345.79M$73.08M$7.09M$229.67M$6.06M
2023-12-31$329.38M$95.19M$11.57M$190.93M$4.85M
2023-09-30$323.92M$87.04M$12.08M$190.42M$3.7M
2023-06-30$315.14M$79.68M$11.62M$188.18M$2.65M
2023-03-31$291.31M$81.42M$11.98M$187.62M$31,000.00
2022-12-31$299.34M$73.62M$4.61M$187.08M$31,000.00
2022-09-30$247.98M$68.56M$3.92M$138.51M$311,000.00
2022-06-30$244.67M$64.55M$6.63M$138.07M$848,000.00
2022-03-31$241.17M$66.49M$11.09M$137.64M$214,000.00
2021-12-31$209.13M$79.04M$8.92M$88.07M$1.68M
2021-09-30$133.72M$37.29M$4.29M$87.71M$1.9M
2020-12-31$125.39M$28.21M$3.12M$87.02M$3.53M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.